Blood Glucose Monitoring Devices Market Trends

  • Report ID: 4606
  • Published Date: Sep 10, 2025
  • Report Format: PDF, PPT

Blood Glucose Monitoring Devices Market Growth Drivers and Challenges:

Growth Drivers

  • Increase in the Number of Patients with type-1 or Insulin-Dependent type-2 Diabetes – Glucose monitoring system helps to monitor the diabetes at an earlier stage, so that the proper treatment can be given at right time such human insulin is generally used to control blood sugar level in people dealing with type 1 diabetes or type 2 diabetesFor instance, according to a report in 2021, it was evaluated that the incidence of type-1 diabetes was 149.5 per 1000 children and the global prevalence was around 9.8% among the total population.

  • Rising Ubiquity of Diabetes – For instance, in 2021, China, Mexico, India, the United States, and Brazil accounted for around 50% of the global diabetes population.
  • Increase in the Number of Patients with type-1 or Insulin-Dependent type-2 Diabetes – For instance, according to a report in 2021, it was evaluated that the incidence of type-1 diabetes was 149.5 per 1000 children and the global prevalence was around 9.8% among the total population.
  • Growing Investment in Diabetic Research Activities – In the United States, more than USD 860 million were invested in over 4,800 diabetes research projects over the last 70 years.
  • Increasing Access to Health Care and Health Expenditures - As per the data from the World Bank, 9.83% of the global GDP was spent on health expenditures in 2019.

Challenges

  • Lower Diagnosis & Treatment Rate of Diabetes – In developing and underdeveloped countries, a large proportion of people remain undiagnosed owing to a lack of awareness and associated costs. Moreover, lack of access to medical facilities and poor healthcare infrastructure are also major concerns for the lower treatment rates of diabetes in such regions. Therefore, this factor is estimated to hinder blood glucose monitoring devices market growth over the projected time frame.

  • Low Reimbursement Policies for the Blood Glucose Monitoring System
  • Inadequate Approach to Advanced Healthcare Infrastructure

Base Year

2025

Forecast Period

2026-2035

CAGR

8.2%

Base Year Market Size (2025)

USD 19.71 billion

Forecast Year Market Size (2035)

USD 43.35 billion

Regional Scope

  • North America (U.S. and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of blood glucose monitoring devices is assessed at USD 21.16 billion.

The global blood glucose monitoring devices market size was valued at around USD 19.71 billion in 2025 and is projected to grow at a CAGR of more than 8.2%, reaching USD 43.35 billion revenue by 2035.

North America blood glucose monitoring devices market is predicted to capture 38.8% share by 2035, driven by rising diabetes cases and increasing adoption of advanced monitoring devices.

Key players in the market include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Ascensia Diabetes Care Holdings AG, Dexcom, Inc., NIPRO CORPORATION, Prodigy Diabetes Care, LLC, ACON Laboratories, Inc., Insulet Corporation, Ypsomed AG, Terumo Corporation.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos